Patents
Patents for C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof (10,673)
11/2000
11/30/2000WO2000025725A3 Functional antagonists of hedgehog activity
11/29/2000EP1055685A1 Non-antigenic branched polymer conjugates
11/29/2000EP1054998A1 Transglutaminase linkage of agents to tissue
11/29/2000EP1054984A1 Monovalent, multivalent, and multimeric mhc binding domain fusion proteins and conjugates, and uses therefor
11/29/2000CN1275163A Recombinant expression vector of human parathyroid hormone using phosphoribulokinase as fusion partner
11/28/2000US6153728 A protein encoded by an isolated nucleic acid molecule, the complementaray sequence of which hybridizes; producing a specific polyclonal antibodies
11/23/2000WO2000004863A3 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
11/22/2000EP1053258A1 Device for producing polymer support materials in the form of porous polymer beads
11/16/2000WO2000068690A1 Method for detecting proteins under mutual interaction
11/16/2000WO2000034784A9 Protein scaffolds for antibody mimics and other binding proteins
11/16/2000DE19919149A1 Von Interferon alpha-2 abgeleitete Peptid-Homodimere und Peptid-Heterodimere Of interferon alpha-2 derived peptide homodimers and peptide heterodimers
11/15/2000EP1051513A1 Polymeric arrays and methods for their use in binding assays
11/14/2000US6147203 Recombinant disulfide-stabilized polypeptide fragments having binding specificity
11/10/2000CA2307446A1 Complex for transferring an anionic substance of interest into a cell
11/09/2000WO2000066156A1 Death domain containing receptor 5
11/09/2000CA2369371A1 Death domain containing receptor 5
11/07/2000US6143864 Peptides
11/07/2000US6143493 HCMV-specific peptides, agents therefor and the use thereof
11/02/2000WO2000064936A2 PEPTIDE HOMODIMERS AND PEPTIDE HETERODIMERS, DERIVED FROM INTERFERON α2
11/02/2000CA2371662A1 Peptide homodimers and peptide heterodimers, derived from interferon .alpha.2
10/2000
10/31/2000US6140072 Functional recombinantly prepared synthetic protein polymer
10/26/2000WO2000063373A1 A method of altering the properties of a membrane-associated protein by substitution of the transmembrane domain
10/26/2000WO2000062758A1 A method for improving the half-life of soluble viral-specific ligands on mucosal membranes
10/26/2000CA2369762A1 A method for improving the half-life of soluble viral-specific ligands on mucosal membranes
10/25/2000EP1046652A1 Method for quantitating denatured ldls
10/25/2000EP1046421A2 Methods and reagents for very large scale immobilized polymer synthesis
10/19/2000WO2000061813A1 A second mammalian tankyrase
10/19/2000WO2000061194A2 Short-chain peptide dye conjugates used as contrast agents for optical diagnostics
10/19/2000WO2000061069A2 Methods and compositions for use in the treatment of hyperlipidemia
10/19/2000DE19917713A1 Kurzkettige Peptid-Farbstoffkonjugate als Konstrastmittel für die optische Diagnostik Short-chain peptide-dye conjugates as contrast agents for optical diagnostics
10/19/2000CA2368490A1 Short-chain peptide dye conjugates used as contrast agents for optical diagnostics
10/19/2000CA2360318A1 A second mammalian tankyrase
10/18/2000EP1044375A1 Method comprising capture molecule fixed on disc surface
10/18/2000EP0885393A4 Graphitic nanotubes in luminescence assays
10/17/2000US6133431 Adsorbent for immunoglobulins and complexes thereof, adsorption method, and adsorption device
10/17/2000US6133418 Synthetic peptide inhibitors of HIV transmission
10/17/2000CA2178752C N-terminally chemically modified protein compositions and methods
10/12/2000WO2000060090A1 Compounds and methods for the diagnosis and treatment of b. microti infection
10/11/2000EP0749435B1 Interference suppression agent for use in immuno assaying
10/10/2000US6130202 Antiviral methods
10/05/2000WO2000058005A2 Immunoadsorber for use in sepsis therapy
10/05/2000DE19913707A1 Immunadsorber zur Sepsistherapie Immuno therapy for sepsis
10/04/2000EP1041149A2 Vaccine and antitoxin for treatment and prevention of C. difficile disease
10/04/2000EP1040122A1 Protein binding polypeptides
10/04/2000EP1039921A1 Substantially pure histidine-linked protein polymer conjugates
10/04/2000EP1039873A1 Keratin-based hydrogel for biomedical applications and method of production
10/03/2000US6127339 Peptide for binding thereto a low density lipoprotein
10/03/2000US6127139 Method for assaying proteolytic enzymes using fluorescence-quenched substrates
09/2000
09/28/2000WO2000056774A1 Methods of using bioelastomers
09/27/2000CN1268142A Aminoalkyl trialkyl silyl cellulose and method for coating surfaces
09/27/2000CN1268062A Modified polypeptides with high activity and reduced allergenicity
09/27/2000CN1056851C Cyclic adhesion inhibitors
09/26/2000US6124128 Nucleic acid coding green fluorescent protein; for use as marker of gene expression, tracers of cell lineage and as fusion tags to monitor protein localization within viable cells
09/26/2000US6124117 Polysaccharide binding fusion proteins and conjugates
09/26/2000US6124102 Methods for determining receptor-ligand binding using probe arrays
09/20/2000EP1036798A1 Peptides having anti-cell adhesion activity
09/19/2000US6121238 Peptides and compounds that bind to a receptor
09/14/2000WO2000053631A1 Mammalian cytokines; related reagents and methods
09/14/2000CA2366706A1 Mammalian cytokines; related reagents and methods
09/13/2000EP1034273A1 Histamine and serotonin binding molecules
09/13/2000EP1034183A1 Carrier-reporter bead assemblies
09/12/2000US6117974 For screening bioactive molecules; compounds have n-alpha derivative amino acids linked by bridging group of disulfide, amide, thioether, thioester, imine, ether, or alkene to terminus located at a side chain or a backbone nitrogen
09/12/2000CA1341095C Cdna coding for the human von willebrand factor, plasmids or phages with such a cdna coding or fragments thereof respectively, micro-organisms and animal or human cell which contain such plasmids or phages, preparation of proteins by the cultivation of the above mentioned hosts, the obtained proteins and pharmaceutical compositions containing a biologically
09/06/2000EP1032676A2 $i(CHLAMYDIA TRACHOMATIS) GENOMIC SEQUENCE AND POLYPEPTIDES, FRAGMENTS THEREOF AND USES THEREOF, IN PARTICULAR FOR THE DIAGNOSIS, PREVENTION AND TREATMENT OF INFECTION
09/06/2000EP0631502B1 Lymphocyte activity regulation by hla peptides
09/05/2000US6114180 Human cardiac troponin
09/05/2000US6114115 Detecting heterozygosity or a mutation in heterozygous form in a sample; labeling nucleic acids, denaturing nucleic acids, incubating with nucleic acid binding protein, detecting bound heteroduplexes
09/05/2000US6113906 Water-soluble non-antigenic polymer linkable to biologically active material
09/05/2000CA2006596C Chemically-modified g-csf
08/2000
08/31/2000WO2000050570A2 Compositions and methods for modulating growth or differentiation of growth-factor dependent cells
08/31/2000WO2000023472A3 Interferon-beta fusion proteins and uses
08/30/2000EP0759937B1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis c virus
08/22/2000CA2056381C Cysteine thiol-protected peptides for use in immunoassays
08/17/2000WO2000018823A3 Peg-based macromonomers, chemically inert polymers prepared therefrom and the use of these polymers for organic synthesis and enzyme reactions
08/15/2000US6103236 In which a compound having an affinity for a target cell is bound to a toxin through a spacer consisting essentially of polyalkylene glycol and a dipeptide.
08/10/2000WO2000010599A8 IMMUNOGENIC β-PROPIONAMIDO-LINKED POLYSACCHARIDE PROTEIN CONJUGATE USEFUL AS A VACCINE PRODUCED USING AN N-ACRYLOYLATED POLYSACCHARIDE
08/09/2000EP1025129A1 Monoclonal antibody to alpha2-macroglobulin and its use for detecting glucan
08/09/2000EP1025118A1 Spacer peptides and membranes containing same
08/02/2000EP1023317A1 Coding combinatorial libraries with fluorine tags
08/01/2000US6096386 Bodies have at least partially a predetermined chemical composition and may comprise molecules, macromolecules or also nanostructures composed of molecules or macromolecules
07/2000
07/27/2000WO2000043791A2 Rapid and sensitive detection of aberrant protein aggregation in neurodegenerative diseases
07/27/2000WO2000029548A3 Coupled peptides
07/27/2000CA2361013A1 Rapid and sensitive detection of aberrant protein aggregation in neurodegenerative diseases
07/26/2000EP0904541A4 PURIFICATION OF TISSUE PLASMINOGEN ACTIVATOR (tPA)
07/25/2000US6093549 Identifying candidate therapeutic agents which interfere with huntingtin associated protein-1(hap1) and huntingtin binding by contacting these proteins and a compound, determining if the compound diminishes the two proteins from binding
07/25/2000CA2109727C Tumor rejection antigen precursors, tumor rejection antigens and uses thereof
07/20/2000WO2000042069A1 Bone stimulating factor
07/20/2000CA2358908A1 Bone stimulating factor
07/19/2000EP1019528A1 Method for assaying proteolytic enzymes using fluorescence-quenched substrates
07/19/2000EP1019441A2 ANTI-BiP-ANTIBODIES IN RHEUMATOID ARTHRITIS, METHOD AND TEST KITS FOR DETECTING THEM
07/19/2000EP0856155A4 Fluorescent and luminescent labelling compositions and methods for their use
07/18/2000US6090912 Multiplicity of separate solid supports with surface having suceptible linker to single species of test compound and with interior having attached non-cleavable coding molecule; for screening ligands or acceptors
07/18/2000US6090292 Device for purifying solutions containing proteins and use of the device
07/12/2000EP1018344A2 HLA-restricted hepatitis B virus CTL epitopes
07/12/2000EP0662000B1 Antigen-carrying microparticles and their use in the induction of humoral or cellular responses
07/11/2000US6087452 Ethylene oxide-propylene oxide copolymer and metal chelate compound
07/11/2000US6087335 Administering a polypeptide isolated from coriolus versicolor as an antitumor agent
07/11/2000US6087170 VZV gene, mutant VZV and immunogenic compositions
07/11/2000US6087102 Biopolymer targets immobilized on a surface of a rigid solid support; for gene expression analysis
07/05/2000EP1015027A2 Process for preparing conjugate vaccines including free protein and the conjugate vaccines, immunogens, and immunogenic reagents produced by this procedure
1 ... 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 ... 107